Surmodics Price to Book Ratio 2010-2024 | SRDX
Historical price to book ratio values for Surmodics (SRDX) over the last 10 years. The current price to book ratio for Surmodics as of April 24, 2025 is 3.53.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Surmodics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-04-24 | 29.40 | 3.76 | |
| 2024-12-31 | 39.60 | $7.82 | 5.06 |
| 2024-09-30 | 38.78 | $8.30 | 4.67 |
| 2024-06-30 | 42.04 | $8.28 | 5.08 |
| 2024-03-31 | 29.34 | $8.69 | 3.38 |
| 2023-12-31 | 36.35 | $8.58 | 4.24 |
| 2023-09-30 | 32.09 | $8.47 | 3.79 |
| 2023-06-30 | 31.31 | $7.95 | 3.94 |
| 2023-03-31 | 22.78 | $7.26 | 3.14 |
| 2022-12-31 | 34.12 | $7.60 | 4.49 |
| 2022-09-30 | 30.40 | $7.73 | 3.93 |
| 2022-06-30 | 37.23 | $8.94 | 4.17 |
| 2022-03-31 | 45.33 | $9.53 | 4.76 |
| 2021-12-31 | 48.15 | $9.78 | 4.92 |
| 2021-09-30 | 55.60 | $10.08 | 5.52 |
| 2021-06-30 | 54.25 | $10.15 | 5.34 |
| 2021-03-31 | 56.07 | $10.25 | 5.47 |
| 2020-12-31 | 43.52 | $9.71 | 4.48 |
| 2020-09-30 | 38.91 | $9.59 | 4.06 |
| 2020-06-30 | 43.24 | $9.57 | 4.52 |
| 2020-03-31 | 33.32 | $9.18 | 3.63 |
| 2019-12-31 | 41.43 | $9.07 | 4.57 |
| 2019-09-30 | 45.74 | $9.07 | 5.04 |
| 2019-06-30 | 43.17 | $8.79 | 4.91 |
| 2019-03-31 | 43.48 | $8.55 | 5.09 |
| 2018-12-31 | 47.26 | $8.43 | 5.61 |
| 2018-09-30 | 74.65 | $8.11 | 9.21 |
| 2018-06-30 | 55.20 | $8.15 | 6.78 |
| 2018-03-31 | 38.05 | $8.56 | 4.45 |
| 2017-12-31 | 28.00 | $8.38 | 3.34 |
| 2017-09-30 | 31.00 | $8.52 | 3.64 |
| 2017-06-30 | 28.15 | $8.34 | 3.37 |
| 2017-03-31 | 24.05 | $8.24 | 2.92 |
| 2016-12-31 | 25.40 | $8.08 | 3.14 |
| 2016-09-30 | 30.09 | $8.09 | 3.72 |
| 2016-06-30 | 23.48 | $7.88 | 2.98 |
| 2016-03-31 | 18.41 | $7.60 | 2.42 |
| 2015-12-31 | 20.27 | $7.33 | 2.77 |
| 2015-09-30 | 21.84 | $7.10 | 3.08 |
| 2015-06-30 | 23.42 | $6.89 | 3.40 |
| 2015-03-31 | 26.03 | $6.55 | 3.98 |
| 2014-12-31 | 22.10 | $6.31 | 3.50 |
| 2014-09-30 | 18.16 | $7.26 | 2.50 |
| 2014-06-30 | 21.42 | $6.96 | 3.08 |
| 2014-03-31 | 22.60 | $6.67 | 3.39 |
| 2013-12-31 | 24.39 | $6.53 | 3.74 |
| 2013-09-30 | 23.78 | $6.75 | 3.52 |
| 2013-06-30 | 20.01 | $6.87 | 2.91 |
| 2013-03-31 | 27.25 | $7.00 | 3.89 |
| 2012-12-31 | 22.36 | $6.73 | 3.32 |
| 2012-09-30 | 20.22 | $6.48 | 3.12 |
| 2012-06-30 | 17.30 | $8.53 | 2.03 |
| 2012-03-31 | 15.37 | $8.32 | 1.85 |
| 2011-12-31 | 14.66 | $8.16 | 1.80 |
| 2011-09-30 | 9.10 | $7.96 | 1.14 |
| 2011-06-30 | 11.10 | $9.01 | 1.23 |
| 2011-03-31 | 12.50 | $8.74 | 1.43 |
| 2010-12-31 | 11.87 | $8.85 | 1.34 |
| 2010-09-30 | 11.92 | $8.86 | 1.35 |
| 2010-06-30 | 16.41 | $10.03 | 1.64 |
| 2010-03-31 | 20.94 | $10.02 | 2.09 |
| 2009-12-31 | 22.66 | $10.03 | 2.26 |
| 2009-09-30 | 24.60 | $9.87 | 2.49 |
| 2009-06-30 | 22.63 | $9.59 | 2.36 |
| 2009-03-31 | 18.25 | $9.28 | 1.97 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.394B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |